MLNT - Melinta Therapeutics Inc. (MLNT) CEO John Johnson on Q4 2018 Results - Earnings Call Transcript
Melinta Therapeutics, Inc. (MLNT)
Q4 2018 Earnings Conference Call
March 13, 2019 4:30 PM
Company Participants
Susan Blum - Vice President, Finance
John Johnson - Chief Executive Officer and Director
Peter Milligan - Chief Financial Officer
Conference Call Participants
Louise Chen - Cantor Fitzgerald & Co
David Hoang - Jefferies
Ed Arce - H.C. Wainwright & Co
Kevin Kedra - G Research
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Melinta Therapeutics Fourth Quarter and Full Year 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
I